drug
as of 2026-07-01JX11502MA
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Zhejiang Jingxin Pharmaceutical Co., Ltd.
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia.
NCT06356389Phase 1, Phase 2Completed
A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule
NCT05233657Phase 1Unknown
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication